Current perspectives on camptothecins in cancer treatmentDANCEY, J; EISENHAUER, E. A.British journal of cancer. 1996, Vol 74, Num 3, pp 327-338, issn 0007-0920Article

A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomasDURAN, I; KORTMANSKY, J; BIRLE, D et al.British journal of cancer. 2006, Vol 95, Num 9, pp 1148-1154, issn 0007-0920, 7 p.Article

Effect of carbohydrate or carbohydrate plus medium-chain triglyceride ingestion on cycling time trial performanceANGUS, D. J; HARGREAVES, M; DANCEY, J et al.Journal of applied physiology (1985). 2000, Vol 88, Num 1, pp 113-119, issn 8750-7587Article

A phase I-II study of 9-cis retinoic acid and interferon-α2b in patients with advanced renal-cell carcinoma : An NCIC Clinical Trials Group studyMILLER, W. H; REYNO, L. M; DANCEY, J et al.Annals of oncology. 2000, Vol 11, Num 11, pp 1387-1389, issn 0923-7534Article

Quality of life scores : An independent prognostic variable in a general population of cancer patients receiving chemotherapyDANCEY, J; ZEE, B; OSOBA, D et al.Quality of life research. 1997, Vol 6, Num 2, pp 151-158, issn 0962-9343Article

Lessons learned from independent central reviewFORD, R; SCHWARTZ, L; VERWEIJ, J et al.European journal of cancer (1990). 2009, Vol 45, Num 2, pp 268-274, issn 0959-8049, 7 p.Article

Phase II study of first-line LY231514 (multi-targeted antifolate) in patients with locally advanced or metastatic colorectal cancer : An NCIC Clinical Trials Group studyCRIPPS, C; BURNELL, M; JOLIVET, J et al.Annals of oncology. 1999, Vol 10, Num 10, pp 1175-1179, issn 0923-7534Article

A multicentre phase II study of carboplatin and prolonged oral etoposide in the treatment of cancer of unknown primary site (CUPS)WARNER, E; GOEL, R; GALLANT, G et al.British journal of cancer. 1998, Vol 77, Num 12, pp 2376-2380, issn 0007-0920Article

Agents targeting ras signaling pathwayDANCEY, J. E.Current pharmaceutical design. 2002, Vol 8, Num 25, pp 2259-2267, issn 1381-6128, 9 p.Article

Phase I trial of UCN-01 in combination with topotecan in patients with advanced solid cancers : a Princess Margaret Hospital Phase II Consortium studyHOTTE, S. J; OZA, A; WINQUIST, E. W et al.Annals of oncology. 2006, Vol 17, Num 2, pp 334-340, issn 0923-7534, 7 p.Article

Phase II study of pegylated liposomal doxorubicin HCl (Caelyx) in combination with cyclophosphamide and vincristine as second-line treatment of patients with small cell lung cancerLEIGHL, Natasha B; GOSS, G. D; SHEPHERD, F. A et al.Lung cancer. 2006, Vol 52, Num 3, pp 327-332, issn 0169-5002, 6 p.Article

Validation of novel imaging methodologies for use as cancer clinical trial end-pointsSARGENT, D. J; RUBINSTEIN, L; SCHWARTZ, L et al.European journal of cancer (1990). 2009, Vol 45, Num 2, pp 290-299, issn 0959-8049, 10 p.Article

Molecular targeting: PI3 kinase pathwayDANCEY, J. E.Annals of oncology. 2004, Vol 15, pp iv233-iv239, issn 0923-7534, SUP4Conference Paper